Solid-State Interactions at the Core-Coat Interface: Physicochemical Characterization of Enteric-Coated Omeprazole Pellets Without a Protective Sub-Coat

被引:0
作者
Vishnu Dutt Sharma
Suleyman Akocak
Marc A. Ilies
Reza Fassihi
机构
[1] Temple University School of Pharmacy,Department of Pharmaceutical Sciences
来源
AAPS PharmSciTech | 2015年 / 16卷
关键词
alkalinizing excipient; DSC; enteric coating; florescence microscopy; functional coating layer(s); HPLC; NMR; omeprazole stability;
D O I
暂无
中图分类号
学科分类号
摘要
Conventionally, scanning electron or transmission microscopy, Raman and near infrared (NIR) spectroscopy, terahertz, florescence, and nuclear magnetic resonance imaging have been used to characterize functional coating structure. This study highlights the use of fluorescence microscopy to investigate the physicochemical stability and coating integrity of the commercially available enteric-coated omeprazole pellets containing a basic excipient and prepared by extrusion and spheronization or drug layering on the nonpareil seed, immediately followed by enteric coating (i.e., absence of protective sub-coat). The nature of coating interface and the likely development of an in situ interfacial layer after the application of enteric coating solution was examined using HPLC, NMR, differential scanning calorimetry (DSC), and fluorescent imaging methods. Likewise for the characterization of the solid pellet structure via fluorescence microscopy, a new approach based on fracturing technique (to avoid surface contamination) rather than microtome sectioning was used and validated. Analytical data showed that the pellets containing omeprazole remained chemically stable (>99.5% recovered). Control of the microenvironmental pH by the addition of alkalinizing excipient within a core formulation or as part of drug layering on top of nonpareil seed appears to efficiently neutralize the acidic effect of enteric coating dispersion. Fluorescence images further illustrate the absence of any discernable in situ layer formation at the coat-core interface.
引用
收藏
页码:934 / 943
页数:9
相关论文
共 57 条
[1]  
Robinson M(2005)Proton pump inhibitors: update on their role in acid-related gastrointestinal diseases Int J Clin Pract 59 709-15
[2]  
Hershcovici T(2011)Pharmacological management of GERD: where does it stand now? Trends Pharmacol Sci 32 258-64
[3]  
Fass R(1987)Structure-activity-relationships of omeprazole analogs and their mechanism of action Trends Pharmacol Sci 8 399-402
[4]  
Lindberg P(1983)Effect of omeprazole-a gastric proton pump inhibitor-on pentagastrin stimulated acid secretion in man Gut 24 270-6
[5]  
Brandstrom A(1985)Development of an oral formulation of omeprazole Scand J Gastroenterol 20 113-20
[6]  
Wallmark B(2000)Enteric coated hard gelatin capsules Capsugel Libr 145 1-17
[7]  
Lind T(1999)In vitro release modulation from crosslinked pellets for site-specific drug delivery to the gastrointestinal tract. I. Comparison of pH-responsive drug release and associated kinetics J Control Release 59 229-42
[8]  
Cederberg C(2012)Colon targeted drug delivery system—a novel perspective Asian J Biomed Pharm Sci 2 21-8
[9]  
Ekenved G(1995)Stability of omeprazole solutions at various pH values as determined by HPLC Drug Dev Ind Pharm 21 965-71
[10]  
Haglund U(2006)Solid state interactions between the proton pump inhibitor omeprazole and various enteric coating polymers J Pharm Sci 95 1342-53